COPD Emergency Department Outcomes 
EMDocs
FEBRUARY 12, 2024
Louis); Marina Boushra, MD (EM-CCM, Cleveland Clinic Foundation); Brit Long, MD (@long_brit) Case Emergency Medical Services brings in a 62-year-old male with COPD in acute on chronic hypoxemic respiratory failure (usually on 3 L nasal cannula, now on non-rebreather at 15 L/min). Int J Emerg Med. Eur J Emerg Med.
Canadian EM
MAY 18, 2023
In this issue, we collaborated with CJEM team to present “Emergency department crowding negatively influences outcomes for adults presenting with chronic obstructive pulmonary disease”1 in a visual abstract format. A majority of these patients are affected by chronic obstructive pulmonary disease (COPD).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Skeptics' Guide to EM
JULY 20, 2024
Case: A 70-year-old man presents to the emergency department (ED) with an exacerbation of COPD. These results are promising and may influence future guidelines and clinical practices, emphasizing the importance of optimizing preoxygenation strategies to improve outcomes in critically ill patients.
The Skeptics' Guide to EM
APRIL 8, 2023
There have been many “temporary” rural emergency department closures during the past last year. In Ontario alone there have been approximately 160 emergency departments (ED) temporarily closed since the beginning of 2022. It was a stepped-wedge reconfiguration of the entire Danish emergency healthcare system.
PulmCCM
OCTOBER 23, 2023
Read in JAMA Does Paxlovid Improve Covid-19 Outcomes in the Omicron Era? Even people with COPD or asthma under age 50 did not benefit from Paxlovid, in that analysis. absolute risk reduction in the composite outcome among the immunocompromised or those with significant medical conditions. Paxlovid was associated with about a 1.5-2.5%
The Skeptics' Guide to EM
SEPTEMBER 25, 2021
Most emergency department patients meeting sepsis criteria are not diagnosed with sepsis at discharge. Guest Skeptic: Dr. Jess Monas is a Consultant in the Department of Emergency Medicine at the Mayo Clinic Hospital, Phoenix, Arizona. Date: September 20th, 2021 Reference: Litell et al. He’s afebrile.
The Skeptics' Guide to EM
JANUARY 22, 2022
There is strong evidence that systemic steroids improve outcomes in patients with severe COVID-19 ( First10EM: Steroids for COVID ). Their primary outcome was a ‘COVID-19 related’ urgent care visit, emergency department assessment, or hospitalization, and was significantly reduced in the budesonide arm (15% vs 3%, p=0.009).
Expert insights. Personalized for you.
94 
Let's personalize your content